Marshall JL - Search Results

1

Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment.

Fu AZ, Graves KD, Jensen RE, Marshall JL, Formoso M, Potosky AL. Fu AZ, et al. Among authors: marshall jl. J Cancer Res Clin Oncol. 2016 Mar;142(3):699-706. doi: 10.1007/s00432-015-2073-4. Epub 2015 Nov 18. J Cancer Res Clin Oncol. 2016. PMID: 26577827 Free PMC article.

2

Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.

Marshall JL, Richmond E, DeLap RJ. Marshall JL, et al. Clin Cancer Res. 1996 Sep;2(9):1475-80. Clin Cancer Res. 1996. PMID: 9816323

3

Capecitabine in colorectal cancer.

Marshall JL. Marshall JL. Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):41-6; discussion 46-7. Oncology (Williston Park). 2001. PMID: 11219977 Free article. Review.

4

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Fried K, Williams M, Lefebvre P, Dahut W, Hanfelt J, Gehan E, Figuera M, Hawkins MJ, Rizvi NA. Bhargava P, et al. Among authors: marshall jl. Cancer Chemother Pharmacol. 2001 Aug;48(2):95-103. doi: 10.1007/s002800100317. Cancer Chemother Pharmacol. 2001. PMID: 11561784 Clinical Trial.

5

A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer.

Rizvi NA, Humphrey JS, Ness EA, Johnson MD, Gupta E, Williams K, Daly DJ, Sonnichsen D, Conway D, Marshall J, Hurwitz H. Rizvi NA, et al. Clin Cancer Res. 2004 Mar 15;10(6):1963-70. doi: 10.1158/1078-0432.ccr-1183-02. Clin Cancer Res. 2004. PMID: 15041713 Clinical Trial.

6

A phase II trial of ISIS 3521 in patients with metastatic colorectal cancer.

Marshall JL, Eisenberg SG, Johnson MD, Hanfelt J, Dorr FA, El-Ashry D, Oberst M, Fuxman Y, Holmlund J, Malik S. Marshall JL, et al. Clin Colorectal Cancer. 2004 Nov;4(4):268-74. doi: 10.3816/ccc.2004.n.026. Clin Colorectal Cancer. 2004. PMID: 15555210 Clinical Trial.

7

The role of bevacizumab as first-line therapy for colon cancer.

Marshall J. Marshall J. Semin Oncol. 2005 Dec;32(6 Suppl 9):S43-7. doi: 10.1053/j.seminoncol.2005.06.003. Semin Oncol. 2005. PMID: 16399431 Review.

8

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

Dritschilo A, Huang CH, Rudin CM, Marshall J, Collins B, Dul JL, Zhang C, Kumar D, Gokhale PC, Ahmad A, Ahmad I, Sherman JW, Kasid UN. Dritschilo A, et al. Among authors: marshall j. Clin Cancer Res. 2006 Feb 15;12(4):1251-9. doi: 10.1158/1078-0432.CCR-05-1260. Clin Cancer Res. 2006. PMID: 16489081 Clinical Trial.

9

The impact of targeted therapy on the treatment of colorectal cancer.

Marshall JL, Hwang J. Marshall JL, et al. Oncology (Williston Park). 2005 Nov;19(13 Suppl 6):19-24. Oncology (Williston Park). 2005. PMID: 16502666 Free article. Review.

10

Optimum use of biologics and role of maintenance therapy in colon cancer.

Marshall J. Marshall J. Semin Oncol. 2006 Dec;33(6 Suppl 11):S33-5. doi: 10.1053/j.seminoncol.2006.10.008. Semin Oncol. 2006. PMID: 17178283 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters